Related references
Note: Only part of the references are listed.Roundabout 4 Regulates Blood-Tumor Barrier Permeability Through the Modulation of ZO-1, Occludin, and Claudin-5 Expression
Heng Cai et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Induction of tumor inhibitory anti-angiogenic response through immunization with interferon Gamma primed placental endothelial cells: ValloVax (TM)
Thomas E. Ichim et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Robo4 vaccines induce antibodies that retard tumor growth
Xiaodong Zhuang et al.
ANGIOGENESIS (2015)
Bacterial surface display of endoglin by antigen 43 induces antitumor effectiveness via bypassing immunotolerance and inhibition of angiogenesis
Feng-Ying Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature
John G. Facciponte et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
Gregory T. Motz et al.
NATURE MEDICINE (2014)
Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. Results of the CENTAURO antigen dose escalation phase I clinical trial
J. V. Gavilondo et al.
VACCINE (2014)
The impact of the immune system on tumor: angiogenesis and vascular remodeling
Christian Stockmann et al.
FRONTIERS IN ONCOLOGY (2014)
Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition
Christopher Daly et al.
CANCER RESEARCH (2013)
Human umbilical vein endothelial cell vaccine therapy in patients with recurrent glioblastoma
Minoru Tanaka et al.
CANCER SCIENCE (2013)
Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor
Hidetoshi Hayashi et al.
CANCER SCIENCE (2013)
Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents
M. Jarosz et al.
GENE THERAPY (2013)
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
Hiroyuki Suzuki et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Function of Survivin in Trophoblastic Cells of the Placenta
Cornelia Muschol-Steinmetz et al.
PLOS ONE (2013)
Purification and characterization of a soluble calnexin from human placenta
Dorthe T. Olsen et al.
PROTEIN EXPRESSION AND PURIFICATION (2013)
Effect of blockade of the EGF system on wound healing in patients vaccinated with CIMAvax® EGF
Aymara Fernandez Lorente et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis
Kayoko Hosaka et al.
NATURE COMMUNICATIONS (2013)
Tumor Endothelial Cells Acquire Drug Resistance by MDR1 Up-Regulation via VEGF Signaling in Tumor Microenvironment
Kosuke Akiyama et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors
Maddalena Arigoni et al.
ANGIOGENESIS (2012)
Human Placental Expression of SLIT/ROBO Signaling Cues: Effects of Preeclampsia and Hypoxia
Wu-Xiang Liao et al.
BIOLOGY OF REPRODUCTION (2012)
Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors
Isamu Okamoto et al.
CANCER SCIENCE (2012)
PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells
Yuan Xue et al.
NATURE MEDICINE (2012)
Cancer and Pregnancy: Parallels in Growth, Invasion, and Immune Modulation and Implications for Cancer Therapeutic Agents
Shernan G. Holtan et al.
MAYO CLINIC PROCEEDINGS (2012)
Tumor Endothelial Cells
Andrew C. Dudley
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Increased Vascular Delivery and Efficacy of Chemotherapy after Inhibition of Platelet-Derived Growth Factor-B
Beverly L. Falcon et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
Effect of a Novel DNA Vaccine on Angiogenesis and Tumor Growth In Vivo
Kibwei A. McKinney et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2010)
Orally Administered DNA Vaccine Delivery by Attenuated Salmonella typhimurium Targeting Fetal Liver Kinase 1 Inhibits Murine Lewis Lung Carcinoma Growth and Metastasis
Shu Guang Zuo et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
Angiogenic factor signaling regulates centrosome duplication in endothelial cells of developing blood vessels
Sarah M. Taylor et al.
BLOOD (2010)
Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma
Alvaro Lladser et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Construction of a DNA vaccine encoding Flk-1 extracellular domain and C3d fusion gene and investigation of its suppressing effect on tumor growth
Pei-he Liang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer
Motoki Miyazawa et al.
CANCER SCIENCE (2010)
Therapy fails, patients don't
Lee M. Ellis et al.
NATURE MEDICINE (2010)
Dendritic cells transduced with TEM8 recombinant adenovirus prevents hepatocellular carcinoma angiogenesis and inhibits cells growth
Xuemei Yang et al.
VACCINE (2010)
Endosialin: from vascular target to biomarker for human sarcomas
Rebecca G. Bagley
BIOMARKERS IN MEDICINE (2009)
Characterization of TEM1/endosialin in human and murine brain tumors
Eleanor B. Carson-Walter et al.
BMC CANCER (2009)
Survivin: A new target for anti-cancer therapy
Brid M. Ryan et al.
CANCER TREATMENT REVIEWS (2009)
Human Hepatocellular Carcinoma Tumor-derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells
Yu-Quan Xiong et al.
CLINICAL CANCER RESEARCH (2009)
Vaccination with xenogeneic tumor endothelial proteins isolated in situ inhibits tumor angiogenesis and spontaneous metastasis
Wang Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
High Harvest Yield, High Expansion, and Phenotype Stability of CD146 Mesenchymal Stromal Cells from Whole Primitive Human Umbilical Cord Tissue
Rebecca C. Schugar et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2009)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line
Kenta Yoshiura et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
An Anti-Vascular Endothelial Growth Factor Receptor 2/Fetal Liver Kinase-1 Listeria monocytogenes Anti-Angiogenesis Cancer Vaccine for the Treatment of Primary and Metastatic Her-2/neu+ Breast Tumors in a Mouse Model
Matthew M. Seavey et al.
JOURNAL OF IMMUNOLOGY (2009)
DNA Vaccine Against Tumor Endothelial Marker 8 Inhibits Tumor Angiogenesis and Growth
Zhihua Ruan et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells
Sven Christian et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Anti-angiogenesis: making the tumor vulnerable to the immune system
Arjan W. Griffioen
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Preoperative plasma endoglin levels predict biochemical progression after radical prostatectomy
Robert S. Svatek et al.
CLINICAL CANCER RESEARCH (2008)
Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine
Beatriz Garcia et al.
CLINICAL CANCER RESEARCH (2008)
Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
Cecile Rouleau et al.
CLINICAL CANCER RESEARCH (2008)
Integrin αvβ3-Targeted Cancer Therapy
Zhaofei Liu et al.
DRUG DEVELOPMENT RESEARCH (2008)
Pilot study of anti-angiogenic vaccine using fixed whole endothelium in patients with progressive malignancy after failure of conventional therapy
Yurai Okaji et al.
EUROPEAN JOURNAL OF CANCER (2008)
Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability
Christopher A. Jones et al.
NATURE MEDICINE (2008)
Robo4 counteracts VEGF signaling
Lisette M. Acevedo et al.
NATURE MEDICINE (2008)
Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting
Kristian Pietras et al.
PLOS MEDICINE (2008)
Placental vascularity and growth factor expression in singleton, twin, and triplet pregnancies in the sheep
Kimberly A. Vonnahme et al.
ENDOCRINE (2008)
Genes that distinguish physiological and pathological angiogenesis
Steven Seaman et al.
CANCER CELL (2007)
Synergistic anti-tumor effect of recombinant chicken fibroblast growth factor receptor-1-mediated anti-angiogenesis and low-dose gemcitabine in a mouse colon adenocarcinoma model
Shao-Jiang Zheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag
P. Felicetti et al.
CYTOTHERAPY (2007)
A novel DNA vaccine encoding PDGFRβ suppresses growth and dissemination of murine colon, lung and breast carcinoma
Charles D. Kaplan et al.
VACCINE (2006)
Inhibition of tumor growth with antiangiogenic cancer vaccine using epitope peptides derived from human vascular endothelial growth factor receptor 1
Hidenobu Ishizaki et al.
CLINICAL CANCER RESEARCH (2006)
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth
Lars Holmgren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors
Anita E. M. Dirkx et al.
FASEB JOURNAL (2006)
Immunoplacental therapy, a potential multi-epitope cancer vaccine
A Harandi
MEDICAL HYPOTHESES (2006)
Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice
A Lladser et al.
IMMUNOBIOLOGY (2006)
Phase I trial of a monoclonal antibody specific for αvβ3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion
DG McNeel et al.
CLINICAL CANCER RESEARCH (2005)
Magic roundabout, a tumor endothelial marker: Expression and signaling
P Seth et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2
S Wada et al.
CANCER RESEARCH (2005)
Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium
JR MacFadyen et al.
FEBS LETTERS (2005)
roundabout4 is essential for angiogenesis in vivo
VM Bedell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development
PU Magnusson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
A new perspective on tumor endothelial cells: Unexpected chromosome and centrosome abnormalities
K Hida et al.
CANCER RESEARCH (2005)
Human endosialin (tumor endothelial marker 1) is abundantly expressed in highly malignant and invasive brain tumors
J Brady et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization
E Corsini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Generation of a specific immunological response to FGF-2 does not affect wound healing or reproduction
SM Plum et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2004)
Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity
Y Okaji et al.
CANCER SCIENCE (2004)
Robo4 is a vascular-specific receptor that inhibits endothelial migration
KW Park et al.
DEVELOPMENTAL BIOLOGY (2003)
Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2
JY Liu et al.
BLOOD (2003)
Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice
QM He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Vascular endothelial growth factor receptor-2 induces survival of hematopoietic progenitor cells
B Larrivéé et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
CD105 is important for angiogenesis: evidence and potential applications
SE Duff et al.
FASEB JOURNAL (2003)
Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells
PE Burger et al.
BLOOD (2002)
Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases
RL Wilder
ANNALS OF THE RHEUMATIC DISEASES (2002)
Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains
A Bratt et al.
GENE (2002)
Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis
YW Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen
YQ Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells
K Hattori et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Angiogenesis in the placenta
LP Reynolds et al.
BIOLOGY OF REPRODUCTION (2001)
Angiomotin:: An angiostatin binding protein that regulates endothelial cell migration and tube formation
B Troyanovsky et al.
JOURNAL OF CELL BIOLOGY (2001)
Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development
SM Plum et al.
VACCINE (2000)
Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
YQ Wei et al.
NATURE MEDICINE (2000)
Share Paper
